Quva pharma, INC.:1327585 [19-017387]

Ended Awarded Last action

Contract number
75N90019F00043
Awardee
Awarding agency
Obligated
$4,529

Award facts

Opportunity
Contract value 100% obligated
$4,528.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sugar Land, TX 77478, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$6,988
Original award $11,517

About this award

The NIH Clinical Center issued a delivery order to Quva Pharma, Inc. on September 30, 2019, with a ceiling value of $4,528.93 for sterile compounded pharmaceutical products.

Place of performance is Sugar Land, TX. The order is firm fixed price and was completed by September 26, 2020. No set-aside was used.

Quick answers

Who was awarded contract 75N90019F00043?

75N90019F00043 was awarded to Quva Pharma, Inc. by NIH Clinical Center (National Institutes of Health) on September 30, 2019.

How much is contract 75N90019F00043 worth?

The government has obligated $4,529 on 75N90019F00043.

Is contract 75N90019F00043 an order under another contract?

Yes. 75N90019F00043 is a delivery order under 75N90019D00030, an indefinite delivery contract.

Was contract 75N90019F00043 competed?

The extent of competition for 75N90019F00043 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award